| AEREA Y POSTAL EX-IAAC | 2023 | 125 | KG | 2-(2-(4-Dibenzo[b][1,4] benzothiazepine-6-yl-piperazin-1-yl) ethoxy)ethanol; (E)- but-2-en 2-(2-(4-Dibenzo[b][1,4] benzothiazepine-6-yl-piperazin-1-yl) ethoxy)ethanol; (E)- but-2-en MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 7502.13 |
| AEREA Y POSTAL EX-IAAC | 2023 | 0.079 | KG | QUETIAPINA APTITUD DE SISTEMA, UPS, S/M QUETIAPINE SYSTEM SUITABILITY (25 MG) (MIXTURE CONTAINS QUETIAPINE FUMARATE AND ABOUT 1% E ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO PRESENTACION:1 VIAL X 25 MG, CODIGO: 1592715, LOTE: R081H0 | INDIA | UNITED STATES | 881.17 |
| AEREA Y POSTAL EX-IAAC | 2023 | 25 | KG | 3-(2-(4-(6-FLUORO-1,2-BENZISOX S/M S/M 3-(2-(4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6,7,8,9-TETRAHYDRO-2-METHYL- MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 10154.3 |
| AEREA Y POSTAL EX-IAAC | 2023 | 0.079 | KG | QUETIAPINA SISTEMA DE ADECUACION (USP), USP, S/M QUETIAPINE SYSTEM SUITABILITY (25 MG) (MIXTURE CONTAINS QUETIAPINE FUMARATE AND ABOUT 1% E ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO CODIGO DEL PRODUCTO:1592715, LOTE: R081H0 | INDIA | UNITED STATES | 890.75 |
| AEREA Y POSTAL EX-IAAC | 2023 | 0.097 | KG | LEVOFLOXACINO COMPUESTO RELACIONADO A, USP, S/M LEVOFLOXACIN RELATED COMPOUND A (25 MG) ((S)-9-FLUORO-3-METHYL-10-(PIPERAZIN-1-YL)-7-OXO-2 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO CODIGO DEL PRODUCTO: 1362114, LOTE: R122P0 | INDIA | UNITED STATES | 861.39 |
| AEREA Y POSTAL EX-IAAC | 2023 | 25 | KG | 3-[2-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL]-6,7,8,9-TETRAHYDRO-2-METHYL-4H-PYR 3-[2-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL]-6,7,8,9-TETRAHYDRO-2-METHYL-4H-PYR MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | INDIA | INDIA | 9919.25 |
| AEREA Y POSTAL EX-IAAC | 2023 | 0.056 | KG | PAROXETINA CLORHIDRATO, USP, S/M Paroxetine Hydrochloride (350 mg)/110429-35- 1/R033M1/EAR99 /2934990005 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO PRESENTACION: 1 U = 350 MG , CODIGO: 1500218, LOTE: R033M1 | INDIA | UNITED STATES | 273 |
| AEREA Y POSTAL EX-IAAC | 2023 | 20 | KG | 3-(2-(4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6,7,8,9-TETRAHYDRO-2-METHYL- 3-(2-(4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6,7,8,9-TETRAHYDRO-2-METHYL- MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | INDIA | INDIA | 8029.72 |
| AEREA Y POSTAL EX-IAAC | 2023 | 0.19 | KG | SULPIRIDA IMPUREZA A EP S/M SULPIRIDE IMPURITY A CRS LOTE: L05.00 -- COI : 000515-2023-PERU DEL 21/08/2023 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 1 VIAL(S) PER SALES UNIT; 20 MG PER VIAL, R.D. N° 9289-2023/DIGEMID/DPF/EPC/MINSA CO 00051 | BELGIUM | FRANCE | 257.15 |
| MARITIMA DEL CALLAO | 2023 | 300 | KG | SULPIRIDA S/M S/M Sulpiride MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 26025 |
| AEREA Y POSTAL EX-IAAC | 2023 | 0.19 | KG | SULPIRIDA IMPUREZA B EP S/M SULPIRIDE IMPURITY B CRS LOTE: L03.01 -- COI : 000505-2023-PERU DEL 15/08/2023 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 1 VIAL(S) PER SALES UNIT; 10 MG PER VIAL, R.D. N° 9099-2023/DIGEMID/DPF/EPC/MINSA CO 00050 | KOREA, REPUBLIC OF | FRANCE | 257.15 |
| MARITIMA DEL CALLAO | 2023 | 375 | KG | 2-hydroxy-5-[(E)-2-{4-[(pyridin-2- yl)sulfamoyl]phenyl}diazen-1-yl]benzoic acid S/M S/M 2-hydroxy-5-[(E)-2-{4-[(pyridin-2- yl)sulfamoyl]phenyl}diazen-1-yl]benzoic acid MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 16000 |
